Clinical Trial Update: The Effect of PD01 on Cardiovascular Health and Microbial Environment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PD01 for cardiovascular health and gut microbial environment in overweight and obese individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• PD01

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Overweight, Obesity | Phase 2 | Status: COMPLETED